The Milton And Carroll Petrie Department Of Urology

3y ago
4.03 MB
16 Pages
Last View : 11d ago
Last Download : 5m ago
Upload by : Jayda Dunning

The Milton and Carroll PetrieDepartment ofUrologyS P E C I A LT Y R E P O R T 2 0 1 SurgeryRemoves One of the World’sLargest Cancerous Prostates560 cubic cm volume426 grams weightSee page 8.

Department of Urology Quick Facts 2018–19C L I N I C A L S TAT I S T I C S77,000 8,000 2,000 1,000 Patient VisitsSurgeriesR E S E A R C H & FAC U LT Y S TAT I S T I C S 3.11764022Million in Research FundingPublicationsMajor CasesRobotic Surgery CasesClinical & Research FacultyResidents with 5 Matches for 201917 Locations, Department of Urology, Mount Sinai Health SystemWashington Heights1Mount Sinai Doctors—Faculty Practice5 East 98th StreetNew York, NY 1002910Mount Sinai Doctors—Chelsea325 West 15th StreetNew York, NY 100112Mount Sinai Doctors—Urology Midtown11Mount Sinai Doctors—Tribeca255 Greenwich StreetNew York, NY 10007625 Madison AvenueNew York, NY 100223Mount Sinai Downtown—Union Square10 Union Square EastNew York, NY 100034Mount Sinai West425 West 59th StreetNew York, NY 100195Mount Sinai St. Luke’s1090 Amsterdam AvenueNew York, NY 100256Mount Sinai Doctors—East 85th Street234 E. 85th StreetNew York, NY 100287Mount Sinai Doctors—77th Street Urology445 E. 77th StreetNew York, NY 100758Mount Sinai Doctors—Washington Heights286 Fort Washington Ave.New York, NY 100329Mount Sinai Doctors—Park Avenue1070 Park AvenueNew York, NY 1012812Mount Sinai Brooklyn3131 Kings HighwayBrooklyn, NY 1123414Mount Sinai Doctors—Brooklyn Heights300 Cadman Plaza WestBrooklyn, NY 1120115Mount Sinai Doctors—Scarsdale495 Central Park AvenueScarsdale, NY 1058316Mount Sinai Queens25-10 30th AvenueAstoria, NY 1110217Scarsdale, NY15519Mount Sinai Doctors—West 57th Street200 West 57th StreetNew York, NY 11Mount Sinai Doctors—Jackson Heights37-22 82nd StreetJackson Heights, NY 1137214BROOKLYN13Kings Highway,Brooklyn2

MESSAGE FROM THE CHAIRAsh Tewari, MBBS, MChAs I celebrate my fifth year asChair of Urology at the IcahnSchool of Medicine at MountSinai, I am especially proud ofwhat we achieved this past year.We expanded our expertisein urological subspecialties,successfully managed increasinglycomplex cases, conductedgroundbreaking clinical and basicscience research, and organizedindustry-leading internationalsymposia. At the same time, we handled 20 percent more patient visits,and performed more than 8,000 surgeries, including 2,000 major casesand more than 1,000 robotic surgical procedures.We added five accomplished and renowned faculty this past year.Peter Wiklund, MD, PhD, our new Bladder Cancer Program Director,has the most experience with robot-assisted cystectomy with totallyintracorporeal neobladder in the world. He pioneered this procedurein 2003 and subsequently built the leading cystectomy program at theKarolinska Institute. Dr. Wiklund has performed more than 3,000 roboticoperations and has extensive experience in advanced pelvic oncologicalsurgery in patients where the tumor is growing on several pelvic organs(multi-organ tumor, bladder, prostate, colorectal, ovarian, and uterine).Pasquale Casale, MD, MHA, is a pediatric urologist and expert inperforming minimally invasive robotic surgery for newborns and childrenand sees patients through Mount Sinai Kravis Children’s Hospital.William Atallah, MD, MPH, specializes in endourology and urinarystone disease, and also does general urological procedures.Susan Marshall, MD, practices general urology and performs urologicsurgery. Eric Moskowitz, MD, is a skilled urologic oncologist with aprimary clinical interest in all aspects of robot-assisted surgery forthe management of kidney, bladder, and prostate cancer. I am alsopleased to announce the promotion of Deepak Kapoor, MD, toClinical Professor of Urology.From a case involving one of the largest cancerous prostates everremoved via robotic surgery to finding a unique way to end a 30-yearcase of urethritis, our physicians completed a variety of interestingand complex cases this past year. Please explore our five highlightedcases on pages 8-12. Patient care is a critical component of what wedo in our department. Read about our innovative multidisciplinaryapproach for high-risk prostate cancer on page 14.I am proud of our trailblazing clinical and pure science research. We sawinitial success in our study of Poly-ICLC therapies, and we have starteda unique exploration of using upright MRI as a new tool for cancerdiagnosis. When conducting research, we continue to partner withThe Tisch Cancer Institute at Mount Sinai, a National Cancer Institutedesignated center. More information on all of these exciting researchprojects can be found on pages 12-13. Leading the research chargein the coming year will be Natasha Kyprianou, MBBS, PhD, our newVice-Chair of Basic Science Research. Also joining our research teamas Assistant Professor is Dimple Chakravarty, PhD.We had strong patient and volume growth atMount Sinai West and Mount Sinai St. Luke’s underthe direction of Site Chair Mantu Gupta, MD, andat Mount Sinai Beth Israel through the leadership ofSite Chair Michael Palese, MD. We are grateful thatThe Mount Sinai Hospital was nationally ranked inUrology again by U.S. News & World Report.At the AUA Annual Meeting, we had 500 attendees who witnessedrobotic surgeries for bladder, kidney, and prostate cancer transmittedin 3D. But we don’t just attend industry events — we also create them.The biggest was our 3rd International Prostate Cancer and UrologicOncology Symposium held over three days with 550 attendees. Wehad a record 115 renowned urologic specialists who gave insightfulpresentations on cutting-edge medical advances and groundbreakingtreatment approaches for urologic cancers. The co-director I workedwith on both of these events was Ketan Badani, MD, the Director of theComprehensive Kidney Cancer Program. Check out the Save the Dateinformation on the back cover for future industry events.Our residency program reached a new milestone in the summer of2018 when we became one of only three ACGME urology programsin the United States permitted to train five residents per year. We thensuccessfully matched five outstanding medical students on January 18,2019. Please see our complete roster of talented residents on page 7.A generous donation from one of my patient’s foundation createdMan Cave Health, a unique sports-themed facility with the mission ofgetting men to the doctor to get tested for prostate cancer. Page 15has some terrific photos of our opening event.Thank you for reading our Specialty Report. Please reach out to me withany thoughts or questions at Tewari, MBBS, MChProfessor and Chair,Milton and Carroll Petrie Department of UrologyKyung Hyun Kim, MD System Chair in UrologyIN THIS ISSUE2Quick Facts6Faculty and Residents12Research15Philanthropy4Year in Pictures8Complex Cases14Patient Care16Save the Date3

Year in Pictures3rd International Prostate Cancer and Urologic Oncology SymposiumDecember 2018Above: The 3rd International Prostate Cancer and Urologic OncologySymposium hosted 550 attendees, 115 world-renowned faculty members,and keynote speaker Siddhartha Mukherjee, MD, center, shown withAsh Tewari, MBBS, MCh, left, and Ketan Badani, MD, right.Right: Sujit Nair, PhD, Assistant Professor of Urology at the Icahn School ofMedicine, presented his research findings.AUA Satellite SymposiumMay 2018At the AUA Annual Meeting in Boston, we had500 attendees who witnessed roboticsurgeries for bladder, kidney, and prostatecancer transmitted in 3D.4

Kidney Cancer and Kidney Health FairMarch 2018New York Liberty superstar Kym Hampton and NBA legend Earl “The Pearl” Monroe,seated in the center bottom row, shot hoops and raised awareness with Mount SinaiDepartment of Urology staff and guests.Man Cave Health OpeningJanuary 2019Dean’s Push-Up for Prostate Cancer ChallengeSeptember 2018Ash Tewari, MBBS, MCh, left, and Thomas Milana, Jr. partnered to open Man CaveHealth in January 2019. See more on page 15.Ash Tewari, MBBS, MCh, challengedstaff and guests to do 29 push-ups inhonor of the 29,000 men who lose theirlives to prostate cancer each year.

FacultyAsh Tewari, MBBS,MCh, FRCS (Hon.)System ChairUrologic Oncology,Prostate Cancer,Robotic SurgeryNatasha Kyprianou,MBBS, PhDVice-Chair, BasicScience ResearchMichael A. Palese, MDSite ChairKetan K. Badani, MDVice-ChairEndourology andStone DiseaseUrologic Oncology,Endourology, RoboticSurgeryUrologic Oncology,Kidney Cancer,Robotic SurgeryNatan Bar-Chama,MDJerry Blaivas, MDJillian Capodice, MS,LACErectile Dysfunction,Male Infertility, AndrologyUrogynecology,Voiding Dysfunction,Reconstructive UrologyNorman Coleburn,MDCaner Dinlenc, MD,MBA, FACSGeneral UrologyUrologic Oncology,Kidney Stones,Robotic SurgeryNeil Grafstein, MDAaron Grotas, MDUrologic OncologyMale and Female VoidingDysfunctionReconstructive andTransgender UrologyIsuru Jayaratna, MDSteven A. Kaplan, MDReza Mehrazin, MDJay A. Motola, MDGeneral Urology,Urologic OncologyMen’s Health, BenignProstate DiseaseUrologic Oncology,Robotic SurgeryMale and FemaleUrologyCraig F. Nobert, MDRajveer Purohit, MD,MPHArt Rastinehad, DOAvinash Reddy, MDReconstructive andTransgender UrologyUrologic Oncology,Interventional Urology,Focal TherapyGeneral Urology,Robotic SurgerySovrin M. Shah, MD,FPMRSVannitaSimma-Chiang, MDDoron Stember, MDFemale UrologyGeneral Urology,Female UrologyJeffrey A. Stock, MDCynthia Trop, MDPediatric Urology,Robotic SurgeryGeneral UrologyRobert Valenzuela,MDNikhil Waingankar,MD, MSHPProsthetic Urology,Erectile DysfunctionUrologic OncologyUrologic ResearchBarbara Chubak, MDGeneral Urology, Voidingand Sexual DysfunctionErik Goluboff, MD,MBA, FACSUrologic Oncology,General UrologyJohn Sfakianos, MDUrologic Oncology,Bladder Cancer6Mantu Gupta, MDSite ChairAcupuncture, Nutrition,WellnessMichael J. Droller, MDUrologic OncologyGerald P. Hoke, MD,MPHGeneral UrologyErectile Dysfunction,Male Infertility, Andrology

New AppointeesWilliam Atallah, MD, MPH, specializes inendourology and urinary stone disease,and also performs general urologicalprocedures and treatments such ascircumcision and hydrocele. A memberof the American Medical Association, theAmerican Urological Association, and the EndourologicalSociety, he has published his work and presented atmultiple conferences.Pasquale Casale, MD, MHA, is one of theforemost authorities on pediatric minimallyinvasive surgeries, and a world-renownedpioneer in pediatric robotic surgery. Hefrequently serves as a lecturer and visitingprofessor, both nationally and internationally,on advanced laparoscopy and reconstruction, as well as onendourology and robotic surgery for children. He holds editorialboard positions on many scientific journals and has authoredhundreds of articles, editorials, and book chapters.Susan Marshall, MD, practices generalurology and performs urologic surgery.Dr. Marshall has authored many scientificpapers and presented her research innational and international conferences.She is a board-certified Diplomate of theAmerican Board of Urology, and is a member of the AmericanUrological Association.Eric Moskowitz, MD, specializes in allaspects of robot-assisted surgery forthe management of kidney, bladder, andprostate cancer and treats all aspectsof urological conditions. Dr. Moskowitzhas authored several peer-reviewedpublications and his research has been presented atboth national and international meetings, including theAmerican Urological Association Annual Meeting, the WorldCongress of Endourology, and the Congress of the SociétéInternationale d’Urologie. He has also served as a reviewerfor the Journal of Endourology.Peter Wiklund, MD, PhD, has the greatestexperience with robot-assisted cystectomywith totally intracorporeal neobladder inthe world. He pioneered this procedure in2003 and subsequently built the leadingcystectomy program at the KarolinskaInstitute in Stockholm, Sweden. Dr. Wiklund has performedmore than 3,000 robotic operations and has extensiveexperience in advanced pelvic oncological surgery in patientswhose tumor is growing on several pelvic organs. Dr. Wiklundtravels the world as an invited lecturer at various courses andmaster classes in robotic surgery. Dr. Wiklund is Chairman ofthe scientific working group of the European Urology RoboticSection of the European Association of Urology and is aninternational member of the American Urological Association.Current ResidentsChief ResidentsKyrollis Attalla, MDJulio Chong, MDMiriam Greenstein, MDTed Vellos, MDJared Winoker, MDPGY-4David Ahlborn, MDZeynep Gul, MDMarissa Kent, MDJason Rothwax, MDPeter Sunyaro, MDPGY-3Eric Bortnick, MDChristine Liaw, MDDaniel Rosen, MDRollin Say, MDPGY-2Conner Brown, MDAndrew Katims, MDGregory Mullen, MDAndrew Tam, MDOur UrologyResidency isauthorized bythe ACGMEto train5 residentsper year.Pre-UrologyHarry Anastos, MDShivaramCumarasamy, MDBeth Edelblute, MDShirin Razdan, MD7

COMPLEX CASESRobot-Assisted Surgery for One of the LargestCases of Prostate Cancer in Medical LiteratureIt is rare to find malignancy in prostates larger than 200cc, but one recent case demonstrates how Mount Sinai’sextensive expertise in diagnosis and resection results inpositive outcomes for patients who present with complexprostate cancers.Ash Tewari, MBBS, MChIn January 2018, Avinash Reddy, MD, Assistant Professorof Urology at the Icahn School of Medicine at Mount Sinai,saw a 78-year-old African-American male from StatenIsland who had been referred to Mount Sinai with grosshematuria. Dr. Reddy ordered a complete blood count, whichrevealed a hematocrit of 22.8. But a subsequent CT scan wasnegative for lesions, and a urine cytology test was negativefor malignancy. The patient’s prostate-specific antigen levelwas 90 ng/ml, a strong indicator of prostate cancer, yet thatseemed unlikely when an MRI revealed that his prostate wasapproximately 659 cc.Negative results prompt further testsDetermining that more tests were required, Dr. Reddyproceeded with a cystoscopy with a clot evacuation, but theresults were negative for bladder lesions. However, a biopsyof the patient’s prostate revealed a Gleason 9 (4 5) cancer,with six out of 14 cores testing positive for cancer with 35percent tumor involvement. Based on these results, thepatient was referred to Vinayak Wagaskar, MBBS, MCh,Clinical Fellow at the Department of Urology at Mount Sinai,who ordered an MRI, CT scan, and bone scan to stage thecancer and rule out lymph node and bone metastases.Although the results of the bone and CT scans were negativefor cancer, a May 2018 MRI showed a 3.5 cm lesion in theright mid-gland of the prostate in the peripheral zone and aprostate volume of 560 cc.Results necessitate RALP approachBased on these results, Dr. Wagaskar recommended that thepatient undergo dissection of the prostate and lymph nodesvia robot-assisted laparoscopic prostatectomy (RALP) toenhance precision, minimize blood loss, improve recovery,and accelerate return of continence. A urinary tract infectioncaused by catheter use necessitated a delay so the patientcould undergo antibiotic therapy. In August 2018, the patientwas cleared for RALP, which was performed by a surgicalteam led by Ash Tewari, MBBS, MCh, the Chair of the Miltonand Carroll Petrie Department of Urology at the IcahnSchool of Medicine.After placing the patient in Trendelenburg position andadministering anesthesia, Dr. Tewari made a 4 cm incision atthe left periumbilical area and created a pneumoperitoneum,which was inflated to 15 mm of mercury to enable successfuldissection of the prostate and lymph nodes. He thenintroduced a first-entry 12 mm port on the left side of theumbilicus for the binocular scope and the insertion of theAlexis Contained Extraction System, which features aspecimen containment bag and a guard that protects thebag from instrumentation punctures.Continence and no complicationsOnce the supporting ports were in place for visualization,dissection, and suction irrigation, Dr. Tewari began dissectingthe prostate on the lateral, posterior, and anterior sides.This proved challenging, as the size of the prostate made itdifficult to handle and posed a significant risk for puncturingiliac veins on the lateral side or rupturing neurovascularbundles on the posterior side. The procedure was completedin three hours with no complications, and the patient wasdischarged the next day. The final pathology showed that thepatient had a p2 cancer that was confined to the prostate,which weighed 426 grams.Dr. Wagaskar says the patient’s catheter was removed 12days postop and he has been experiencing 100 percentcontinence. A subsequent cystogram showed no leaksand the patient’s PSA levelswere non-detectable.“To our knowledge, this is oneof the largest cases of prostatecancer removed via robotassisted surgery ever noted inthe medical literature,” says Dr.Wagaskar. “The fact the patientachieved 100 percent continencethe day we removed his catheteris equally noteworthy. This caseis symbolic of the outcomes weare able to achieve at MountSinai, even in rare and complexcases of prostate cancer.”MRI of prostate approximately 560 cubic cm8Prostate weighed 426 grams

Complex Partial Nephrectomy Made PossibleThrough Innovative Technology, Clinical TrialsPartial nephrectomy can pose a considerable challengefor surgeons, even more so in cases involving large tumors,given the ischemia times involved, and the risk of bleedingor a urine leak. At Mount Sinai, new technologies andinnovative surgical approaches are helping to reduce theserisks, making the procedure practical for more patients asdemonstrated by one recent case.In September 2018, Ketan K. Badani, MD, Vice-Chairof Urology and Robotic Operations and Director of theComprehensive Kidney Cancer Program at Mount SinaiHealth System, saw a female patient who had beenexperiencing orthopedic issues due to an automobileaccident. She was referred to Dr. Badani when an ultrasoundrevealed that she had a 6.5 cm right-sided kidney tumor.Low ischemia time, enhanced functional outcomeIn October 2018, Dr. Badani performed a partial nephrectomyassisted by his expert surgical team. He began the procedureby making five key hole incisions in the patient’s abdomen.Using the 3D model for guidance, Dr. Badani applied temporary clamps to both arteries, injected indocyanine green,and then removed each clamp sequentially to confirm thatthe upper pole artery was not perfusing the normal kidney.He then proceeded to clamp the lower artery and, using theFAST approach, he resected the lesion and reconstructedthe defect in only nine minutes. The total blood loss was lessthan 50 ml, and the total time for surgery was under 2 hours.Ketan K. Badani, MDAlthough the optimal approach for a tumor of this sizetypically is a nephrectomy, given the high risk of malignancy,Dr. Badani, who is also Professor of Urology at the IcahnSchool of Medicine at Mount Sinai, knew the patientpreferred a partial nephrectomy. He decided to explore ifsuch an approach was possible by enrolling the patient intoinnovative clinical trials.3D modeling, radiomics facilitatepartial nephrectomy“We are participating in a multicenter study looking at theutility of 3D models to help plan partial nephrectomies,” Dr.Badani says. “These models enable you to look at differentlayers of anatomy to determine if a partial nephrectomy ispossible. We are also involved in a radiomics study in whichwe are exploring the efficacy of using radiology images todetermine disease pathology. I enrolled her in the radiomicsstudy, obtained anMRI of the kidney,and that was thenrendered as a3D model.”The 3D modelrevealed that thepatient had anupper pole arterythat appearedto only perfuse3D model of the kidneythe tumor anda second lowerartery that perfused the normal kidney. Determining thata partial nephrectomy was possible, Dr. Badani decidedthat the best course of treatment would be a robotic partialnephrectomy using a technique he developed, called FAST(First Assistant Sparing Technique), to reduce ischemia timeduring the resection.Operative view of partial nephrectomy, normal kidney on the left, tumor on the right.“Not only is it uncommon to perform a partial nephrectomyon a tumor of this size, but the ischemia times typicallyapproach 30 minutes, which is usually the upper limit ofwhat is considered safe,” Dr. Badani says. “Using advancedtechnologies, and the techniques we have developed atMount Sinai, we have really paved the way in improvingkidney functional outcome over time.”The tumor was completely resected with clear margins, andthe final pathology showed that it was a renal cell carcinoma.The patient was discharged after an overnight stay and hasmaintained a baseline creatinine level of 0.9. She will bemonitored with CT scans at six-month intervals over the nexttwo years, but Dr. Badani considers the patient cured.“This is a case that highlights all the strengths of MountSinai’s kidney cancer program,” Dr. Badani says. “Itdemonstrates that we can do a very safe, clean partialnephrectomy on a very challenging tumor with a verygood outcome, low ischemia times, and low blood loss, allsupported by innovative clinical trials that contribute tooutcome management.”.9

Dorsal Urethral Reconstruction with Buccal GraftProvides Relief in 30-Year Case of UrethritisWhen it comes to a complex case of urethritis, a Mount Sinaisurgeon demonstrates that innovative thinking, pioneeringexpertise, and a dedication to individualized treatment canresult in positive outcomes and a very satisfied patient.Jerry Blaivas, MDIn February 2018, Jerry Blaivas, MD, a senior faculty member inUrology at The Mount Sinai Hospital, consulted with a 63-yearold female patient from Westchester County who had a 30year history of chronic urethritis, and presented with dysuriaand a thin stream. The patient had previously undergonea series of urethral dilations, two urethral meatoplasties,and a ventral vaginal flap urethroplasty in 2013, but she hadsubsequently developed a recurrent stricture. The degree ofsharp, burning pain she experienced was such that she wasinterested in a urinary diversion.Providing an alternate approachWanting to get a better understanding of the patient’ssituation, Dr. Blaivas performed a series of tests, starting witha video urodynamic study, a technique he helped pioneerin the 1970s. It revealed that the patient had a moderatelysevere urethral obstruction with a detrusor pressure atmaximum flow of 63 cm of water and a maximum uroflow ofonly 4 ml per second. A subsequent cystoscopy, performedunder anesthesia, revealed a very distal panurethral pinpointstricture that extended from the bladder neck to the urethralmeatus. The urethral meatus was retracted and neithervisible or palpable due to the patient’s previous surgery.complex case that would be challenging for anyone to treat.But I knew from experience that this could be done dorsally.”After discussing the matter with the patient, Dr. Blaivascarried out the two-hour procedure in September 2018.He began by making a vertical incision above the urethraand, using Metzenbaum scissors, continued the dissectionproximally under the pubis until entering the retropubicspace. He passed a bougie a boule through the urethra todetermine the proximal extent of the stricture and made avertical midline incision, which was extended until it was easyto pass a 26 French bougie. Dr. Blaivas then placed a 3x3 cmbuccal mucosal graft and tested the repair with the bougie toensure there had been no narrowing of the urethra. The deadspace between the graft and the periurethral musculaturewas closed and the graft was everted at the urethral meatusto prevent stricture.Pain free, voiding wellThe patient was discharged following an overnight stay.Subsequent tests show that her maximum uroflow hasincreased from 4 ml to 21 ml per second and her lower urinarytract symptom score has fallen from 35 to 5. Her bladderdiary reveals that her bladder capacity has increased from303 ml to 426 ml, her voiding difficulties have decreased fromeight to zero per day, and her urgency episodes decreasedfrom six to two per day.“The patient indicated that she has never voided this well inher life,” Dr. Blaivas says. “She also indicated this is the firsttime she hasn’t had pain after her operations. A case likethis demonstrates that Mount Sinai has the experience andthe techniques to consistently achieve good outcomes incomplex cases such as this.”Image of a Video Urodynamic studyDr. Blaivas believed the patient was a good candidatefor a dorsal urethral reconstruction with a buccal graft.“Although urethral strictures in women are uncommon, weare quite experienced with them and have a good successrate. Complications are quite low and, if successful, shewould be spared a much bigger operation with a muchhigher complication rate.” he says. “The scarring fromthe procedures she had undergone, combined with theshortened urethra and small vagina, made this a particularly10

Robotic Surgery Leads to SuccessfulOutcome in Bladder Neck ReconstructionScarring of the bladder neck following a transurethralresection of the prostate (TURP) and radiation therapyposes considerable challenges for treatment. But a recentcase showcases how Mount Sinai can provide patients withoptions for surgical intervention that otherwise would not beavailable to them.“Ultimately, I decided that a two-team robotic reconstructionof the bladder was the optimal approach to treat this patient.It would result in smaller incisions, decreased pain, andenhanced access to the bladder neck, which would facilitatethe procedure and improve patient recovery time,” he says.Robotic approach preserves natural anatomyIn December 2017, a patient was referred to The Mount SinaiHospital with a tight, impassable bladder neck contractureand leakage of urine. Reviewing the patient’s history, RajveerPurohit, MD, MPH, Director of Voiding Dysfunction andReconstructive Urology and Associate Professor of Urologyat the Icahn School of Medicine at Mount Sinai, noted that thepatient had been diagnosed with prostate cancer in 2002and underwent two rounds of radiation therapy resulting inradiation-induced scar tissue.Successive TURPs result in constrictionIn 2015, the patient underwent a Green Light Laserprostate ablation to correct the contracture and relieve theobstructive urinary symptoms he was experiencing, butthe scar tissue subsequently reformed. A second TURPwas performed two years later and several urinary dilationsfollowed. Yet none of these interventions helped and hewas ultimately managed with placement of a suprapubictube. The patient was informed by his urologist that his onlyoptions were further dilations, intermittent catheterization,or a urinary diversion.Dr. Purohit ordered a cystoscopy and retrogradeurethrogram (see Figure 1 and 2), which confirmed thepresence of an almost completely obliterative stricture inthe mid-prostate gland. He knew the location of the stricturewould make it difficult to access through open surgery.“Traditionally, we would have done a pubectomy, but thefact that the patient had undergone radiation created a highrisk of complications, such as chronic pain and pubic boneinfections,” Dr. Purohit says.Working in partnership with Ketan K. Badani, MD, Professorof Urology at the Icahn School of Medicine and Vice-Chair ofUrology and Robotic Operations for the Mount Sinai HealthSystem, the team performed the three-hour procedurein March 2018. Starting with five 1-cm incisions along thepatient’s lower abdomen to permit access for the roboticinstrumentation, the team proceeded to cut open and excise3 cm of scar tissue from the prostate gland. Using the robotto create a new bladder muscle flap, Dr. Purohit and Dr.Badani performed the bladder neck reconstruction. Therewere no complications and the total blood loss was less than20 ml. The patient was discharged the following day.Rajveer Purohit, MD, MPHDr. Purohit says a retrograde urethrogram performed threeweeks postop revealed that the bladder neck had healedcompletely and there were no signs of stricture. Six monthslater the bladder neck remained open (see Figure 3) and thepatient had subsequently undergone a successful artificialurinary sphincter replacement surgery to restorehis continence by Dr. Purohit.“This was a patient who was given limitedoptions for treatment,” says Dr. Purohit.“Despite the considerable challengesposed by his previous surgeries andradiation therapy, we were able topreserve the patient’s natural anatomyinstead of creating a urinary diversion.This demonstrates our ability to handlehighly complicated reconstructions ina way that minimizes patient morbidityand the risk of complications such asincontinence. I think that is somethingfew other centers in the world arecapable of doing when presentedwith a case such as this.”Figure 3Figure 1Figure 211

Unique Approach Enables Single Procedure Treatmentof Peyronie’s Disease, Climacturia, Erectile DysfunctionA patient with post radical prostatectomy iatrogenic Peyronie’sdisease, erectile dysfunction, urinary incontinence, andclimacturia would typically undergo two separate surgeries.However a Mount Sinai surgeon was able to address all theseissues in one procedure using one peno-scrotal incision and anarmamentarium of unique surgical techniques.Loss of length, impaired function followingprostatectomyRobert Valenzuela, MDIn March 2018, Robert Valenzuela, MD, Assistant Professorof Urology and Director of Penile Prosthesis Surgeryat the Icahn School of Medicine at Mount Sinai, saw apatient who had undergone a robot-assisted laparoscopicprostatectomy. Two years after the procedure, the patientexperienced biochemical failure and required androgendeprivation therapy prior to salvage radiation therapy. As aresult, the patient experienced loss of penile length, erectiledysfunction, climacturia, and Peyronie’s disease.The patient was referred to Dr. Valenzuela, and head

General Urology Isuru Jayaratna, MD General Urology, Urologic Oncology Steven A. Kaplan, MD Men’s Health, Benign Prostate Disease Reza Mehrazin, MD Urologic Oncology, Robotic Surgery Jay A. Motola, MD Male and Female Urology Craig F. Nobert, MD Urologic Oncology, General Urology Sovrin M. Shah, MD, FPMRS

Related Documents:

Silat is a combative art of self-defense and survival rooted from Matay archipelago. It was traced at thé early of Langkasuka Kingdom (2nd century CE) till thé reign of Melaka (Malaysia) Sultanate era (13th century). Silat has now evolved to become part of social culture and tradition with thé appearance of a fine physical and spiritual .

May 02, 2018 · D. Program Evaluation ͟The organization has provided a description of the framework for how each program will be evaluated. The framework should include all the elements below: ͟The evaluation methods are cost-effective for the organization ͟Quantitative and qualitative data is being collected (at Basics tier, data collection must have begun)

̶The leading indicator of employee engagement is based on the quality of the relationship between employee and supervisor Empower your managers! ̶Help them understand the impact on the organization ̶Share important changes, plan options, tasks, and deadlines ̶Provide key messages and talking points ̶Prepare them to answer employee questions

Dr. Sunita Bharatwal** Dr. Pawan Garga*** Abstract Customer satisfaction is derived from thè functionalities and values, a product or Service can provide. The current study aims to segregate thè dimensions of ordine Service quality and gather insights on its impact on web shopping. The trends of purchases have

On an exceptional basis, Member States may request UNESCO to provide thé candidates with access to thé platform so they can complète thé form by themselves. Thèse requests must be addressed to esd rize unesco. or by 15 A ril 2021 UNESCO will provide thé nomineewith accessto thé platform via their émail address.

Chính Văn.- Còn đức Thế tôn thì tuệ giác cực kỳ trong sạch 8: hiện hành bất nhị 9, đạt đến vô tướng 10, đứng vào chỗ đứng của các đức Thế tôn 11, thể hiện tính bình đẳng của các Ngài, đến chỗ không còn chướng ngại 12, giáo pháp không thể khuynh đảo, tâm thức không bị cản trở, cái được

John Milton was born on Bread Street, London, on 9 December 1608, as the son of the composer John Milton and his wife Sarah Jeffrey. The senior John Milton (1562–1647) moved to London around 1583 after being disinherited by his devout Catholic father, Richard Milton, for embracing Protesta

5256 Alabama St, Milton October 12. 1-2 p.m. Navy League Santa Rosa Council Meeting Milton Police Department, 5451 Alabama Street October 13. 1-2:30 p.m. Milton Dementia Support Group Milton Community Center, 5629 Byrom St, Room 113 October 14. 7-9 p.m. Bands on the Blackwater 5158 Willing St, Milton